Modulation of the immune response by extracellular matrix proteins

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 6, 2006, Pages 367-374

  Morwood, Sarah R ^a   Nicholson, Lindsay B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Extracellular matrix; Inflammation; Matricellular protein

Indexed keywords

ALPHA3 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BACTERIAL DNA; BIGLYCAN; CD36 ANTIGEN; CD47 ANTIGEN; COMPLEMENT COMPONENT C1Q; DECORIN; GALECTIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; OSTEOPONTIN; PATTERN RECOGNITION RECEPTOR; SCLEROPROTEIN; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR ALPHA;

AUTOIMMUNITY; BINDING SITE; CELL FUNCTION; CELL MIGRATION; CELL POLARITY; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MACROPHAGE FUNCTION; MICROBIAL COLONIZATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, PATTERN RECOGNITION; T-LYMPHOCYTES;

EID: 33845718980     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0043-x     Document Type: Review

References (64)

1. Abbas A. K., Murphy K. M. and Sher A. (1996): Functional diversity of helper T lymphocytes. Nature, 383, 787-793.
2. Adams J. C. and Lawler J. (2004): The thrombospondins. Int. J. Biochem. Cell Biol., 36, 961-968.
3. Adams J. C. and Tucker R. P. (2000): The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development Dev. Dyn., 218, 280-299.
4. Ashkar S., Weber G. F., Panoutsakopoulou V., Sanchirico M. E., Jansson M., Zawaideh S., Rittling S. R., Denhardt D. T., Glimcher M. J. and Cantor H. (2000): Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 287, 860-864.
5. Avice M. N., Rubio M., Sergerie M., Delespesse G. and Sarfati M. (2000): CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. J. Immunol., 165, 4624-4631.
6. Bevilacqua M. P. (1993): Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol., 11, 767-804.
7. Bornstein P. (1995): Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin. 1. J. Cell Biol., 130, 503-506.
8. Bornstein P. and Sage E. H. (2002): Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol., 14, 608-616.
9. Bradshaw A. D. and Sage E. H. (2001): SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest., 107, 1049-1054.
10. Calandra T. (2001): Pathogenesis of septic shock: implications for prevention and treatment. J. Chemother., 13 (spec. no. 1), 173-180.
11. Chabas D., Baranzini S. E., Mitchell D., Bernard C. C., Rittling S. R., Denhardt D. T., Sobel R. A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J. R. and Steinman L. (2001): The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science, 294, 1731-1735.
12. Chieppa M., Bianchi G., Doni A., Del Prete A., Sironi M., Laskarin G., Monti P., Piemonti L., Biondi A., Mantovani A., Introna M. and Allavena P. (2003): Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program J. Immunol., 171, 4552-4560.
13. Comalada M., Cardo M., Xaus J., Valledor A. F., Lloberas J., Ventura F. and Celada A. (2003): Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J. Immunol., 170, 4450-4456.
14. Crawford S. E., Stellmach V., Murphy-Ullrich J. E., Ribeiro S. M., Lawler J., Hynes R. O., Boivin G. P. and Bouck N. (1998): Thrombospondin-1 is a major activator of TGF-betal in vivo. Cell, 93, 1159-1170.
15. Dawes J., Clemetson K. J., Gogstad G. O., McGregor J., Clezardin P., Prowse C. V. and Pepper D. S. (1983): A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb. Res., 29, 569-581.
16. Denhardt D. T., Noda M., O'Regan A. W., Pavlin D. and Berman J. S. (2001): Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest., 107, 1055-1161.
17. Gordon S. (2004): Pathogen recognition or homeostasis? APC receptor functions in innate immunity. CR Biol., 327, 603-607.
18. Groeneveld T. W., Oroszlan M., Owens R. T., Faber-Krol M. C., Bakker A. C., Arlaud G. J., McQuillan D. J., Kishore U., Daha M. R. and Roos A. (2005): Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J. Immunol., 175, 4715-4723.
19. He Y. W., Li H., Zhang J., Hsu C. L., Lin E., Zhang N., Guo J., Forbush K. A. and Bevan M. J. (2004): The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat. Immunol., 5, 88-97.
20. Higashijima S., Nose A., Eguchi G., Hotta Y. and Okamoto H. (1997): Mindin/F-spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev. Biol., 192, 211-227.
21. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T. A., Kageshita T., Saita N. and Nakamura T. (2004): Galectin-9 in physiological and pathological conditions. Glycoconj. J., 19, 593-600.
22. Hocking A. M., Shinomura T. and McQuillan D. J. (1998): Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol., 17, 1-19.
23. Jia W., Li H. and He Y. W. (2005): The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood, 106, 3854-3859.
24. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G. D., Mascarenhas M. M., Garg H. G., Quinn D. A., Homer R. J., Goldstein D. R., Bucala R., Lee P. J., Medzhitov R. and Noble P. W. (2005): Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med., 11 1173-1179.
25. Kuznetsova S. A. and Roberts D. D. (2004): Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int. J. Biochem. Cell Biol., 36, 1126-1134.
26. Lawler J., Sunday M., Thibert V., Duquette M., George E. L., Rayburn H. and Hynes R. O. (1998): Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest., 101, 982-992.
27. Lelongt B. and Ronco P.( 2003): Role of extracellular matrix in kidney development and repair. Pediatr. Nephrol., 18, 731-742.
28. Li S. S., Ivanoff A., Bergstrom S. E., Sandstrom A., Christensson B., van Nerven J., Holgersson J., Hauzenberger D., Arencibia I. and Sundqvist K. G. (2002): T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components. Eur. J. Immunol., 32, 1069-1079.
29. Masli S., Turpie B. and Streilein J. W. (2006): Thrombospondin orchestrates the tolerance-promoting properties of TGF{beta}-treated antigen-presenting cells. Int. Immunol., 18, 689-699.
30. McDonald C. and Nunez G. (2004): Mindin the fort. Nat. Immunol., 5, 16-18.
31. Miyajima-Uchida H., Hayashi H., Beppu R., Kuroki M., Fukami M., Arakawa F., Tomita Y. and Oshima K. (2000): Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci., 41, 561-567.
32. Miyake K. (2003): Innate recognition of lipopolysaccharide by CD14 and Toll-like receptor 4-MD-2: unique roles for MD-2. Int. Immunopharmacol., 3, 119-128.
33. Murphy-Ullrich J. E., Schultz-Cherry S. and Hook M. (1992): Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell, 3, 181-188.
34. Narizhneva N. V., Razorenova O. V., Podrez E. A., Chen J., Chandrasekharan U. M., DiCorleto P. E., Plow E. F., Topol E. J. and Byzova T. V. (2005): Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J., 19, 1158-1160.
35. Nathan C. (2002): Points of control in inflammation. Nature, 420, 846-852.
36. Noble P. W., McKee C. M., Cowman M. and Shin H. S. (1996): Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med., 183, 2373-2378.
37. Norman M. U. and Hickey M. J. (2005): Mechanisms of lymphocyte migration in autoimmune disease. Tissue Antigens, 66, 163-172.
38. Okamura Y., Watari M., Jerud E. S., Young D. W., Ishizaka S. T., Rose J., Chow J. C. and Strauss J. F. 3rd (2001): The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem., 276, 10229-10233.
39. Okuda S., Languino L. R., Ruoslahti E. and Border W. A. (1990): Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest., 86, 453-462.
40. O'Regan, A. W., Hayden J. M. and Berman J. S. (2000): Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J. Leukoc. Biol., 68, 495-502.
41. Renkl A. C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S. F., Simon J. C. and Weiss J. M. (2005): Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood, 106, 946-955.
42. Rollo E. E., Laskin D. L. and Denhardt D. T. (1996): Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J. Leukoc. Biol., 60, 397-404.
43. Samiric T., Ilic M. Z. and Handley C. J. (2004): Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon. Eur. J. Biochem., 271, 3612-3620.
44. Sangaletti S., Gioiosa L., Guiducci C., Rotta G., Rescigno M., Stoppacciaro A., Chiodoni C. and Colombo M. P. (2005): Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J. Cell Sci., 118, 3685-3694.
45. Sato T., Nakai T., Tamura N., Okamoto S., Matsuoka K., Sakuraba A., Fukushima T., Uede T. and Hibi T. (2005): Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut, 54, 1254-1262.
46. Savill J., Hogg N., Ren Y. and Haslett C. (1992): Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest., 90, 1513-1522.
47. Schaefer L., Babelova A., Kiss E., Hausser H. J., Baliova M., Krzyzankova M., Marsche G., Young M. F., Mihalik D., Gotte M., Malle E., Schaefer R. M. and Grone H. J. (2005): The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest., 115, 2223-2233.
48. Schultz-Cherry S., Ribeiro S., Gentry L. and Murphy-Ullrich J. E. (1994): Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem., 269, 26775-26782.
49. Shinohara M. L., Jansson M., Hwang E. S., Werneck M. B., Glimcher L. H. and Cantor H. (2005): T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. USA, 102, 17101-17106.
50. Simon S. I. and Green C. E. (2005): Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng., 7, 151-185.
51. Stark M. A., Huo Y., Burcin T. L., Morris M. A., Olson T. S. and Ley K. (2005): Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity, 22, 285-294.
52. Sun M., Finnemann S. C., Febbraio M., Shan L., Annangudi S. P., Podrez E. A., Hoppe G., Darrow R., Organisciak D. T., Salomon R. G., Silverstein R. L., Hazen S. L. (2006): Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions. J. Biol. Chem., 281, 4222-4230.
53. Takahashi F., Takahashi K., Maeda K., Tominaga S. and Fukuchi Y. (2000): Osteopontin is induced by nitric oxide in RAW 264.7 cells. IUBMB Life, 49, 217-221
54. Vallejo A. N., Mugge L. O., Klimiuk P. A., Weyand C. M. and Goronzy J. J. (2000): Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J. Immunol., 164, 2947-2954.
55. van SchravendijkM. R., Handunnetti S. M., Barnwell J. W. and Howard R. J. (1992): Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood, 80, 2105-2114.
56. Waage A., Brandtzaeg P., Halstensen A., Kierulf P. and Espevik T. (1989): The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med., 169, 333-338.
57. Wilbanks G. A. and Streilein J. W. (1992): Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol., 22, 1031-1036.
58. Xu T., Bianco P., Fisher L. W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A. M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkarni A. B., Robey P. G. and Young M. F. (1998): Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet., 20, 78-82.
59. Yabkowitz R., Dixit V. M., Guo N., Roberts D. D. and Shimizu Y. (1993): Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins. J. Immunol., 151, 149-158.
60. Yamaguchi Y., Mann D. M. and Ruoslahti E. (1990): Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature, 346, 281-284.
61. Yehualaeshet T., O'Connor R., Green-Johnson J., Mai S., Silverstein R., Murphy-Ullrich J. E. and Khalil N. (1999): Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol., 155, 841-851.
62. Yipp B. G., Anand S,. Schollaardt T., Patel K. D., Looareesuwan S. and Ho M. (2000): Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood, 96, 2292-2298.
63. Yung S., Hausser H., Thomas G., Schaefer L., Kresse H. and Davies M. (2004): Catabolism of newly synthesized decorin in vitro by human peritoneal mesothelial cells. Perit. Dial. Int., 24, 147-155.
64. Zhu C., Anderson A. C., Schubart A., Xiong H., Imitola J., Khoury S. J., Zheng X. X., Strom T. B. and Kuchroo V. K. (2005): The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol., 6, 1245-1252.